TrialJournal of gynecologic oncology2024

Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 study.

Hiroaki Itamochi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.